KIT Kitron ASA

MedAvail awards contract to Kitron’s US factory

MedAvail awards contract to Kitron’s US factory

(2020-08-25) MedAvail Technologies has chosen Kitron to produce automated medication dispensing equipment for pharmacies and hospitals.

The contract has a potential value of USD 50 million over a three-year period, with an extension option.

Production will take place at Kitron’s newly renovated facility in Windber, Pennsylvania, and is expected to commence in the first quarter of 2021.

“We have awarded this important contract to Kitron after a thorough process. Among the deciding factors were Kitron’s broad experience with customers in the medical devices industry and its familiarity with the particular requirements this entails. We’re extremely pleased to enter into this production partnership,” said Ed Kilroy, CEO of MedAvail Technologies.

MedAvail has developed a world leading consumer facing pharmacy automation kiosk, the MedAvail MedCenter. This technology is taken to market by MedAvail through their own retail pharmacy network, branded SpotRx Pharmacy. The MedCenter technology, combined with other features, enables SpotRx to deploy directly in-clinic providing on site dispensing and access to a live pharmacist via the MedAvail MedCenter. SpotRx is focused on the US Medicare market. MedAvail also licenses the MedCenter technology to a select group of large retailers and health systems. 

“This agreement is strategically important for Kitron. The upgrades and investments we have made at our US facility played a key role in securing this business, which significantly boosts our presence within the Medical devices market sector in North-America,” said Peter Nilsson, President and CEO of Kitron ASA.

For further information, please contact:

Kitron: Peter Nilsson, President and CEO, tel.  850

Israel Losada Salvador, COO and Sales Director, tel. +47 991 59 138

E-mail:

MedAvail Technologies:

Ed Kilroy, CEO, tel.

Ryan Ferguson, CFO, tel.

E-mail:  

Kitron is a leading Scandinavian electronics manufacturing services company for the Defence/Aerospace, Energy/Telecoms, Industry, Medical devices and Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania, Germany, Poland, China and the United States. Kitron had revenues of about NOK 3.3 billion in 2019 and has about 1 700 employees.  

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

 

EN
25/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kitron ASA

 PRESS RELEASE

Kitron: Allocation of options

Kitron: Allocation of options (2026-02-12) On 12 February 2026, the board of directors of Kitron ASA (the "Company" or "Kitron") resolved to issue 800 000 options under Kitron's long- term incentive program for the period 2024 - 2030. The options are issued with 800 000 options in Subprogram C (2026 - 2029), and in accordance with the board of directors' guidelines for remuneration of senior executives as approved by Kitron's annual general meeting held 25 April 2024. The share option program and properties of the options are a continuation of Kitron's share option program as described in...

 PRESS RELEASE

Kitron: Allokering av opsjoner

Kitron: Allokering av opsjoner (2026-02-12) Styret i Kitron ASA ("Selskapet" eller "Kitron") vedtok 12. februar 2026 å utstede 800 000 opsjoner i henhold til Kitrons langsiktige insentivprogram for perioden 2024 - 2030. Opsjonene blir utstedt med 800 000 opsjoner i C (2026 - 2029), og i henhold til styrets retningslinjer for godtgjørelse til ledende ansatte som vedtatt av ordinær generalforsamlingavholdt 25. april 2024. Aksjeopsjonsprogrammet og egenskapene til opsjonene er en fortsettelse av Kitrons opsjonsprogram som beskrevet i note 19 til Selskapets årsregnskap for 2024. Totalt er det...

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Åsne Holsen
  • Øystein Elton Lodgaard
 PRESS RELEASE

Kitron: Key information relating to the cash dividend to be paid by Ki...

Kitron: Key information relating to the cash dividend to be paid by Kitron ASA * Dividend amount: NOK 0.70 per share * Declared currency: NOK * Last day including right: 24 April 2026 * Ex-date: 27 April 2026 * Record date: 28 April 2026 * Payment date: On or about 15 May 2026* Date of approval: 24 April 2026 This information is published in accordance with the requirements of the Oslo Børs Continuing Obligations for stock exchange listed companies.   This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

 PRESS RELEASE

Kitron: Nøkkelinformasjon knyttet til foreslått kontantutbytte for Kit...

Kitron: Nøkkelinformasjon knyttet til foreslått kontantutbytte for Kitron ASA * Utbyttebeløp: NOK 0,70 per aksje * Annonsert valuta: NOK * Siste dag inklusive: 24. april 2026 * Ex-dato: 27. april 2026 * Record date (eierregistreringsdato): 28. april 2026 * Betalingsdato: På eller rundt 15. mai 2026 * Vedtaksdato: 24. april 2026 Denne informasjonen offentliggjøres i henhold til kravene i Oslo Børs løpende forpliktelser for børsnoterte selskaper. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

ResearchPool Subscriptions

Get the most out of your insights

Get in touch